James “Jimmy” Armstrong hadn’t missed a “Mac” in 28 years. At 44, he’s one of the youngest “goats” in the Chicago Yacht Club. Sailors receive the designation of “goat” once they’ve completed 20 or more “Macs”, the 333-mile boat race from Chicago to Mackinac, Michigan.
Armstrong has sailed the race every year since he was 16. But, he wasn’t among the sailors this past July. Instead, he was in intensive care awaiting heart transplant following a harrowing experience spurred by a severe case of myocarditis—a little-known condition causing inflammation of the heart muscle.
“I don’t remember much of what happened to me. A lot of it is a blur,” said Armstrong, a local business owner and father of three young daughters. “I was thinking I had a bad cold or even food poisoning, and then suddenly my health spiraled out of control.”
Armstrong had no prior history of heart problems. However, persistent bouts of dizziness and nausea sent him into the emergency room of his suburban hospital on June 6. Cardiac imaging confirmed Armstrong had acute myocarditis. While not always life-threatening, in many cases it can lead to heart failure or sudden cardiac death. Physicians believe it is caused by either a viral, bacterial, or fungal infection; drug or chemical poisoning; or connective tissue diseases, such as lupus or rheumatoid arthritis.
According to Northwestern Medicine cardiologist William G. Cotts, MD, patients can often have fever, aches and severe fatigue similar to cold or flu-like symptoms. This can sometimes correct with no lasting damage. But in severe cases like Armstrong’s there’s often the presence of an irregular heartbeat and trouble breathing—and symptoms usually present once the patient is already in heart failure.
This was the case with Armstrong. When he was referred to Northwestern Medicine’s cardiac specialists at the Bluhm Cardiovascular Institute, the myocarditis had so aggressively deteriorated his heart function that full support—in effect an artificial-heart-like device—was his only hope.
Edwin C. McGee, Jr. MD, surgical director for the Bluhm Cardiovascular Institute’s Heart Transplantation and Mechanical Assistance program was Armstrong’s cardiac surgeon. Although Armstrong ultimately required heart transplant, in July he received life-saving intervention where two HeartWare ® ventricular assist devices (VAD) were implanted onto both ventricles of his heart as a “bridge to transplant”, sustaining heart function until a heart became available. This was the first time anywhere in North America—and to date the only—instance of using the small VADs in a biventricular configuration—two VADs instead of one—implanted on a single heart. This particular device is one of the smallest, full-support experimental VADs currently available for study in humans in the US.
This past Oct. 15, Armstrong received a heart transplant. The American Heart Association estimates that an average of 300,000 people die every year from heart failure; 10,000 of them qualify for heart transplant, but only 2000 cardiac transplants occur in the US each year due to lack of organs. Assist devices such as what Armstrong received are becoming an increasingly important therapy to help individuals with advanced heart failure.“I may never know why or how I contracted the myocarditis that destroyed my heart,” Armstrong said. “But I know I wouldn’t be here if Northwestern’s team hadn’t acted as fast as they did to save my life.”
Kris Lathan | EurekAlert!
Biofilm discovery suggests new way to prevent dangerous infections
23.05.2017 | University of Texas at Austin
Another reason to exercise: Burning bone fat -- a key to better bone health
19.05.2017 | University of North Carolina Health Care
Staphylococcus aureus is a feared pathogen (MRSA, multi-resistant S. aureus) due to frequent resistances against many antibiotics, especially in hospital infections. Researchers at the Paul-Ehrlich-Institut have identified immunological processes that prevent a successful immune response directed against the pathogenic agent. The delivery of bacterial proteins with RNA adjuvant or messenger RNA (mRNA) into immune cells allows the re-direction of the immune response towards an active defense against S. aureus. This could be of significant importance for the development of an effective vaccine. PLOS Pathogens has published these research results online on 25 May 2017.
Staphylococcus aureus (S. aureus) is a bacterium that colonizes by far more than half of the skin and the mucosa of adults, usually without causing infections....
Physicists from the University of Würzburg are capable of generating identical looking single light particles at the push of a button. Two new studies now demonstrate the potential this method holds.
The quantum computer has fuelled the imagination of scientists for decades: It is based on fundamentally different phenomena than a conventional computer....
An international team of physicists has monitored the scattering behaviour of electrons in a non-conducting material in real-time. Their insights could be beneficial for radiotherapy.
We can refer to electrons in non-conducting materials as ‘sluggish’. Typically, they remain fixed in a location, deep inside an atomic composite. It is hence...
Two-dimensional magnetic structures are regarded as a promising material for new types of data storage, since the magnetic properties of individual molecular building blocks can be investigated and modified. For the first time, researchers have now produced a wafer-thin ferrimagnet, in which molecules with different magnetic centers arrange themselves on a gold surface to form a checkerboard pattern. Scientists at the Swiss Nanoscience Institute at the University of Basel and the Paul Scherrer Institute published their findings in the journal Nature Communications.
Ferrimagnets are composed of two centers which are magnetized at different strengths and point in opposing directions. Two-dimensional, quasi-flat ferrimagnets...
An Australian-Chinese research team has created the world's thinnest hologram, paving the way towards the integration of 3D holography into everyday...
24.05.2017 | Event News
23.05.2017 | Event News
22.05.2017 | Event News
26.05.2017 | Life Sciences
26.05.2017 | Life Sciences
26.05.2017 | Physics and Astronomy